These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22359532)

  • 21. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.
    Petta S; Grimaudo S; Marco VD; Scazzone C; Macaluso FS; Cammà C; Cabibi D; Pipitone R; Craxì A
    J Viral Hepat; 2013 Jul; 20(7):486-93. PubMed ID: 23730842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
    Ghany MG; Lok AS; Everhart JE; Everson GT; Lee WM; Curto TM; Wright EC; Stoddard AM; Sterling RK; Di Bisceglie AM; Bonkovsky HL; Morishima C; Morgan TR; Dienstag JL;
    Gastroenterology; 2010 Jan; 138(1):136-46. PubMed ID: 19766643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D supplementation for chronic liver diseases in adults.
    Bjelakovic G; Nikolova D; Bjelakovic M; Gluud C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011564. PubMed ID: 29099543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
    Rakoski MO; Brown MB; Fontana RJ; Bonkovsky HL; Brunt EM; Goodman ZD; Lok AS; Omary MB;
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):902-909.e1. PubMed ID: 21782771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection.
    Waldenström J; Nyström K; Nilsson S; Norkrans G; Ydreborg M; Langeland N; Mørch K; Westin J; Lagging M
    PLoS One; 2020; 15(8):e0237840. PubMed ID: 32822420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.
    Wang JB; Abnet CC; Chen W; Dawsey SM; Fan JH; Yin LY; Yin J; Major JM; Taylor PR; Qiao YL; Freedman ND
    Br J Cancer; 2013 Oct; 109(7):1997-2004. PubMed ID: 24008664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus.
    Barchetta I; Carotti S; Labbadia G; Gentilucci UV; Muda AO; Angelico F; Silecchia G; Leonetti F; Fraioli A; Picardi A; Morini S; Cavallo MG
    Hepatology; 2012 Dec; 56(6):2180-7. PubMed ID: 22753133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.
    Falleti E; Bitetto D; Fabris C; Fattovich G; Cussigh A; Cmet S; Ceriani E; Fornasiere E; Pasino M; Ieluzzi D; Pirisi M; Toniutto P
    Hepatology; 2012 Nov; 56(5):1641-50. PubMed ID: 22610885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D status and longitudinal lung function decline in the Lung Health Study.
    Kunisaki KM; Niewoehner DE; Singh RJ; Connett JE
    Eur Respir J; 2011 Feb; 37(2):238-43. PubMed ID: 20595151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
    Bruno CM; Valenti M; Bertino G; Ardiri A; Consolo M; Mazzarino CM; Amoroso A; Neri S
    Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Measurement of 25-Hydroxyvitamin-D in Chronic HBV Patients Using LC-MS/MS.
    Gao W; Wei L; Zhao J; Yang X; Han Y; Liu Y; Duan Z; Xu B
    Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection.
    Cholongitas E; Theocharidou E; Goulis J; Tsochatzis E; Akriviadis E; Burroughs K
    Aliment Pharmacol Ther; 2012 Mar; 35(6):634-46. PubMed ID: 22316435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.
    Bitetto D; Fabris C; Fornasiere E; Pipan C; Fumolo E; Cussigh A; Bignulin S; Cmet S; Fontanini E; Falleti E; Martinella R; Pirisi M; Toniutto P
    Transpl Int; 2011 Jan; 24(1):43-50. PubMed ID: 20649944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D serum level is associated with Child-Pugh score and metabolic enzyme imbalances, but not viral load in chronic hepatitis B patients.
    Zhao XY; Li J; Wang JH; Habib S; Wei W; Sun SJ; Strobel HW; Jia JD
    Medicine (Baltimore); 2016 Jul; 95(27):e3926. PubMed ID: 27399065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders.
    Basile U; Napodano C; Pocino K; Barini A; Marino M; Santini SA; Barini A; Stefanile A; Basile V; Callà CA; Cattani P; Gasbarrini A; Rapaccini GL; Gulli F
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8506-8514. PubMed ID: 31646582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing The Relation Between Vitamin D Deficiency and Progression of Medial Femoro-tibial Osteoarthitis of the Knee.
    Bassiouni H; Aly H; Zaky K; Abaza N; Bardin T
    Curr Rheumatol Rev; 2017; 13(1):65-71. PubMed ID: 27041085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.
    Petta S; Cammà C; Scazzone C; Tripodo C; Di Marco V; Bono A; Cabibi D; Licata G; Porcasi R; Marchesini G; Craxí A
    Hepatology; 2010 Apr; 51(4):1158-67. PubMed ID: 20162613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.